Overview of Home Infusion Administration Methods
One of the growing areas of healthcare is home infusion therapy (HIT). It is estimated that HIT will have an annual growth rate of 7.5% through 2028. This modality helps reduce costs and increases patient convenience; however, a gap exists between HIT and clinician knowledge, which can lead to suboptimal outcomes. Learn more about HIT and its challenges.

Preventing Amiodarone-Induced Phlebitis
According to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation report, IV amiodarone is an appropriate alternative for rate control and may facilitate the conversion to sinus rhythm. However, this guideline fails to caution about the potential for drug-induced phlebitis associated with the use of the IV amiodarone. Read more.

Aspirin Alternative to LMWH for Thromboembolic Prevention
Clinical practice guidelines recommend the use of thromboprophylaxis following the occurrence of orthopedic trauma to prevent the development of deep vein thromboses and pulmonary embolisms. However, no head-to-head clinical trials exist comparing the use of aspirin, an inexpensive oral antiplatelet agent, to the use of low-molecular-weight heparin (LMWH) for venous thromboembolic prophylaxis. Read more.